On December 17 officials from Guatemala, Honduras, El Salvador and Nicaragua finished negotiations with the United States on the Central American Free Trade Agreement (CAFTA). CAFTA is a bad deal, one that promises to extend the harmful impacts of NAFTA to Mexico’s weaker southern neighbors.
At the same time, boosters like US Trade Representative Robert Zoellick are premature in declaring victory for their hemispheric “free trade” agenda. A week of intense negotiations in Washington demonstrated that developing countries are not as easily browbeaten as in the past. And the coming fight to stop ratification of the agreement will likely show opponents of corporate globalization to be in a stronger position than ever.
The CAFTA text itself exhibits signs of a delicate political compromise. Zoellick’s office has emphasized the decline in tariffs on consumer and industrial products that would go into effect with the agreement. But the United States and Central American countries alike exempted their most sensitive goods from immediate competition. The United States maintained protections for sugar and textile industries in exchange for exceptionally laggard phase-out periods of up to twenty years for tariffs on Central American corn, dairy and other farm products.
For activists, other aspects of CAFTA should provide greater cause for concern than the hotly contested trade provisions. The removal of investment barriers will further open public enterprises in Central American countries to privatization. Moreover, the deal contains dispute-resolution mechanisms similar to NAFTA’s Chapter 11, which allows corporations to sue governments for regulations (including the enforcement of local environmental laws) that they believe infringe on their rights.
CAFTA stipulations defending intellectual property threaten to move AIDS treatment beyond the reach of many Central Americans in need. “Generic competition has lowered HIV drug costs,” says Asia Russell of the nonprofit Health GAP. “If Bush gets his way, CAFTA will lock countries into tough new patent rules that will drive the cost of life-saving drugs up and delay or obstruct generic competition.”
Finally, Thea Lee, assistant director of the public policy department at the AFL-CIO, notes that CAFTA will diminish pro-worker safeguards present in the Caribbean Basin Trade Partnership Act. “Zoellick says that this agreement includes unprecedented protections for labor. That’s a flat-out lie,” she argues. While the previous initiative mandated that participating countries uphold internationally recognized labor norms, the new agreement only requires that governments enforce their own laws, which are often far weaker.
For these reasons, a ratified CAFTA would represent a clear blow to poor and working people in the Americas. This outcome is anything but certain, however. The Bush Administration has stumbled through a series of trade setbacks in past months–the collapse of WTO talks in Cancún, the dilution in Miami of plans for a Free Trade Area of the Americas and the delay of bilateral trade negotiations with Australia and Morocco–leaving supporters of such deals in desperate need of forward momentum.